MP asks government to authorise local manufacture of drug for rare disease to slash cost

A Rajya Sabha MP urges the health minister to enable local production of Risdiplam, a vital drug for spinal muscular atrophy, to reduce costs. Current patents prevent affordable production. Encouraging local manufacturing could make the drug accessible at significantly reduced prices, benefiting thousands of patients in India.